Skip to main content
Diabetes Care logoLink to Diabetes Care
. 2020 Jun 11;43(7):1670. doi: 10.2337/dc20-er07

Erratum. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020;43:487–493

John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D’Alessio, Melanie J Davies
PMCID: PMC7411277  PMID: 32444453

The incorrect figure legend was printed for Figure 2. The first sentence of the legend should read as follows: “Choosing glucose-lowering medication in those with indicators of high-risk or established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or heart failure (HF).”

The online version of the article (https://doi.org/10.2337/dci19-0066) has been updated to correct this error.


Articles from Diabetes Care are provided here courtesy of American Diabetes Association

RESOURCES